Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted proapoptotic anticancer drug delivery system.

Pooja Chandna1, Maha Saad, Yang Wang

  • 1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.

Molecular Pharmaceutics
|August 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanoflower-like 2D WSe<sub>2</sub>-wrapped 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene heterostructure for supercapacitor applications.

Scientific reports·2026
Same author

Chelator-engineered nano-electroless copper coatings on epoxides: surface and electrochemical properties.

Scientific reports·2026
Same author

Clinical Pharmacists and Industry: Guidelines for Professional Interactions.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Benoxinate-Induced Keratopathy: Clinical Patterns and Management, a Cairo University Residents' Report.

Eye & contact lens·2026
Same author

Dual calcium-ACE inhibition reverses non alcoholic fatty pancreas progression: Mechanistic convergence on miR-762/GPX4 driven NLRP3 inflammasome activation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Is pre-operative computed tomography mandatory in the workup of open globe injuries?

Emergency radiology·2026

A novel drug delivery system (DDS) combines poly(ethylene glycol) (PEG), camptothecin (CPT), LHRH peptide, and BH3 peptide to target cancer cells. This proapoptotic DDS demonstrated enhanced anticancer efficacy by inducing apoptosis and inhibiting cell survival mechanisms.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Developing targeted drug delivery systems (DDS) is crucial for enhancing cancer therapy efficacy and minimizing side effects.
  • Conventional chemotherapy faces challenges like poor bioavailability and non-specific targeting.
  • Overcoming cancer cells' intrinsic antiapoptotic defense mechanisms is a key therapeutic goal.

Purpose of the Study:

  • To develop and evaluate a novel, targeted, proapoptotic anticancer drug delivery system (DDS).
  • To investigate the in vitro and in vivo performance of a multi-component DDS.
  • To assess the synergistic effects of combining apoptosis induction and antiapoptotic defense inhibition within a single DDS.

Main Methods:

  • Conjugation of poly(ethylene glycol) (PEG) with camptothecin (CPT), LHRH peptide, and BH3 peptide to create a multicomponent DDS.

Related Experiment Videos

  • Characterization of the DDS structure using atomic force microscopy (AFM).
  • In vitro and in vivo evaluation of DDS accumulation, cellular uptake, and therapeutic efficacy in cancer models.
  • Main Results:

    • The targeted DDS preferentially accumulated in tumor tissues.
    • Active ingredients were successfully delivered into the cytoplasm and nuclei of cancer cells.
    • Simultaneous apoptosis induction and inhibition of BCL2 protein significantly enhanced cytotoxicity and antitumor activity.
    • The DDS with two copies of each active component per PEG molecule exhibited the highest anticancer efficiency.

    Conclusions:

    • The developed targeted proapoptotic DDS offers a promising strategy for cancer treatment.
    • The combination of targeting, apoptosis induction, and antiapoptotic suppression leads to superior anticancer effects compared to individual components.
    • The optimized DDS formulation demonstrates significant potential for clinical translation in oncology.